Azenta, Inc. insider trading
Every open-market purchase and sale by Azenta, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Azenta, Inc.’s insiders pay?
From May 12, 2010 to May 19, 2026, 34 insiders reported 11 open-market purchases and 141 sales not made under a pre-set plan in Azenta, Inc. Twelve months after each purchase was reported, the shares were +2.6% against the S&P 500 on average (median −25.1%), over 10 purchases with a full year of prices; 20% beat the index. After sales, the shares moved +16.7% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on February 12, 2016 into $23,815 by November 2, 2026, +8.4% a year. It held shares 37% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $20,707 (+7.0% a year), and held throughout $48,199 (+15.8%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Pietrantoni David | Principal Accounting Officer | 0 | — | — | 18 | +17.0% (18) | November 19, 2021 |
| Jarzynka David | President, Semi Solutions | 0 | — | — | 16 | +13.0% (16) | November 22, 2021 |
| Robertson Lindon G | EVP & Chief Financial Officer | 2 | +56.4% (2) | 50% | 14 | +30.4% (14) | August 22, 2022 |
| Montone William T. | SVP, Human Resources | 0 | — | — | 15 | +30.9% (15) | November 20, 2020 |
| Joseph Jason | SVP, General Counsel, Secy. | 0 | — | — | 13 | +17.2% (13) | November 21, 2024 |
| Gray David C | Chief Strategy & New Business | 0 | — | — | 11 | +27.3% (11) | August 14, 2023 |
| Schwartz Stephen S | CEO | 0 | — | — | 10 | +21.0% (10) | November 19, 2021 |
| Tenney Maurice H. | President-Brooks Life Sciences | 0 | — | — | 10 | +21.4% (10) | February 15, 2019 |
| Martin Joseph R | Director | 0 | — | — | 8 | +22.2% (8) | June 7, 2023 |
| Mirchandani Kush | SVP, Worldwide Sales | 0 | — | — | 3 | −5.1% (3) | December 6, 2013 |
| Cornog William L | Director | 2 | −32.4% (1) | 0% | 0 | — | May 19, 2026 |
| Cueto Herman | EVP, Chief Financial Officer | 0 | — | — | 2 | −39.4% (2) | November 21, 2024 |
| Liao Guojuan | President, GENEWIZ | 0 | — | — | 2 | +37.9% (2) | November 20, 2020 |
| Mcgillicuddy John K | Director | 0 | — | — | 2 | +27.3% (2) | November 24, 2015 |
| Rosenblatt Michael | Director | 0 | — | — | 2 | −26.0% (2) | November 15, 2021 |
| Vacha Robin | SVP, GM BLS-Products | 0 | — | — | 2 | −0.1% (2) | November 19, 2021 |
| Woollacott Alfred III | Director | 0 | — | — | 2 | +29.2% (2) | May 10, 2019 |
| Zhou Ginger | SVP and General Manager, Genom | 1 | −62.2% (1) | 0% | 1 | −35.2% (1) | February 4, 2025 |
| Allen A Clinton | Director | 1 | +133.1% (1) | 100% | 0 | — | February 11, 2016 |
| Crowley Kimberly | SVP, Chief HR Officer | 0 | — | — | 1 | −48.1% (1) | June 7, 2022 |
| Davis Robyn C | Director | 0 | — | — | 1 | +57.2% (1) | November 16, 2016 |
| De Jesus Linda | Chief Commercial Officer, LS | 0 | — | — | 1 | −26.8% (1) | February 3, 2022 |
| Haris Clinton M. | SVP, Brooks Life Sciences | 0 | — | — | 1 | −30.2% (1) | March 12, 2012 |
| Hirsch Didier | Director | 1 | −32.4% (1) | 0% | 0 | — | November 19, 2024 |
| Hughes Violetta | VP, Chief Accounting Officer | 0 | — | — | 1 | −62.2% (1) | February 4, 2025 |
| Lin Lawrence Y. | EVP, CFO and Treasurer | 1 | −17.7% (1) | 0% | 0 | — | August 12, 2025 |
| Madaus Martin D | Director | 1 | −32.4% (1) | 0% | 0 | — | November 19, 2024 |
| Marotta John | President and CEO | 1 | −32.4% (1) | 0% | 0 | — | November 19, 2024 |
| Marvell Gregory | VP, Extended Factory Group | 0 | — | — | 1 | −10.7% (1) | February 8, 2011 |
| Mathews Timothy S | Principal Accounting Officer | 0 | — | — | 1 | −22.3% (1) | May 24, 2013 |
| Mcmanus Matthew | EVP & Chief Operating Officer | 1 | −10.2% (1) | 0% | 0 | — | August 22, 2022 |
| Pirogova Olga | SVP and CHRO | 0 | — | — | 1 | −35.2% (1) | November 21, 2024 |
| Wang David Dong | SVP & GM, SMS | 0 | — | — | 1 | −35.2% (1) | November 21, 2024 |
| Wilson Shaun | VP, Global Customer Operations | 0 | — | — | 1 | +27.5% (1) | June 10, 2010 |
When several insiders traded Azenta, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Azenta, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 2 buying crowds with six months of prices, it averaged +0.8% against the index. After 10 selling crowds, +13.3%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| November 29, 2024 | 5 selling | −8.5% | −37.6% | −37.8% |
| August 31, 2022 | 2 buying | +10.6% | −18.3% | −8.9% |
| November 30, 2021 | 7 selling | −20.1% | −24.2% | −37.6% |
| November 30, 2020 | 7 selling | +6.6% | +21.1% | +28.1% |
| June 30, 2020 | 4 selling | −1.7% | +41.5% | +75.7% |
| November 29, 2019 | 8 selling | −20.0% | −6.9% | +47.2% |
| November 30, 2018 | 7 selling | +6.8% | +23.8% | +20.1% |
| March 29, 2018 | 3 selling | +15.1% | +16.8% | +1.3% |
| November 30, 2017 | 8 selling | +7.2% | +29.8% | +17.2% |
| November 30, 2016 | 10 selling | +20.0% | +62.2% | +32.5% |
| February 29, 2016 | 2 buying | +5.2% | +19.8% | +96.4% |
| September 30, 2014 | 3 selling | +16.1% | +6.6% | +16.2% |